Catalonia and Castilla-La Mancha prepare for lung cancer screening from 2027
Published
The Spanish Society of Pneumology and Thoracic Surgery (SEPAR) has highlighted the CASSANDRA project as a key element for launching lung cancer screening with low-dose computed tomography (CT) in Catalonia and Castilla-La Mancha. According to the organisation, this programme will drive the development of this early detection test from 2027.
Lung cancer is one of the most common and deadliest tumours in Spain. For this reason, experts believe that detecting it at an early stage, before symptoms appear, can greatly improve the chances of a cure. Low-dose CT is a test that uses less radiation than a conventional CT scan and makes it possible to identify small nodules in the lungs.
The CASSANDRA project aims to prepare the introduction of this type of screening in the two autonomous communities. Among other things, the programme must organise the people who can take part, define how the tests will be carried out and decide how the results will be followed up. SEPAR considers this work necessary so that screening works in an orderly way and with guarantees.
In conclusion, according to SEPAR, the launch of lung cancer screening in Catalonia and Castilla-La Mancha will depend on the development of the CASSANDRA project. The planned date is 2027, and the medical society will closely follow the progress of the initiative.
Sources: Demócrata
More Spain news
- CSIC researcher wins award for best scientific manuscript of 2026
- The University of Valencia examines restorative justice versus multi-crime in Colombia
- Spain shines at El Ojo 2026 with 95 awards and five Grand Ojos
- Spain and England face each other in the UEFA Nations League: how to watch the match live
- Castellón beat Valladolid at Zorrilla and improve their chances of promotion
- Fan sentenced to 11 months in prison for racist abuse of Mbappé at the Tartiere
- United States and Haiti to meet on 18 November 2026: what we know about the match
- Isabel Santos, Marketing Director at Hefame, receives an innovation award